Germany’s largest pharmaceutical medical service company and private hospital operator: Fresenius SE & Co. (FSNUY)

Fresenius SE & Co. KGaA (OTC PINK: FSNUY, FWB: FRE) was founded in 1912, Fresenius SE & Co. KGaA (OTC PINK: FSNUY, FWB: FRE), formerly known as Fresenius SE, was changed to its current name in January 2011 and is headquartered in Bad, Germany Homburg vor der Höhe, with 275,674 full-time employees, is a healthcare group that provides products and services for dialysis, hospitals and outpatient care. It is the largest pharmaceutical medical service company and private hospital operator in Germany, and the largest dialysis service company in the world— -The parent company of Fresenius Medical Products .


Fresenius SE & Co. (FSNUY):

Fresenius SE & Co. KGaA (Fresenius SE & Co. KGaA) is a German medical technology and healthcare company headquartered in Bad Homburg, Hessen. It is one of the Fortune 500 companies in the world. Germany’s largest pharmaceutical medical service company and private hospital operator, was formally established as a European stock company on July 13, 2007, and became a component company of the German DAX index on March 23, 2009. In addition, Fresenius also holds a majority stake in Fresenius Medical Care , a dialysis company .

Fresenius is divided into 4 departments to operate : Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.

1. Fresenius Medical Care department : Provide products and services for patients with chronic renal failure. This department provides dialyzers, hemodialysis machines and related disposable products, as well as dialysis related services.

2. Fresenius Kabi Department : Specializing in the treatment and care of chronic and critically ill patients. This section provides intravenous drugs, including intravenous general anesthetics, analgesics, anti-infectives, and drugs for the treatment of tumors and other severe diseases; parenteral and enteral nutrition products; infusion and blood transfusion treatments; infusion and nutrition pumps , And consumables; and products used to collect and process blood components and transfusion medicine.

3. The Fresenius Helios department : operates 111 hospitals with approximately 35,000 beds, including 88 acute care hospitals and 23 acute care clinics; 4 post-acute care centers; 17 prevention centers; and 12 nursing homes.

4. Fresenius Vamed Department : Manage projects and provide services to hospitals and other medical institutions. This department provides project development, planning and turnkey construction services, as well as maintenance, technical management and operation management services.

Currently, Fresenius’ subsidiaries include:

  • Fresenius Medical Services AG : The world’s leading provider of dialysis equipment and products, one of the constituent companies of the German DAX index.
  • Fresenius Kabi : A supplier in the field of intravenous treatment and clinical nutrition. Its business areas also include infusion and blood transfusion technology and outpatient medical services.
  • 费森尤斯赫Rios : Private hospital operator by Wirtgen Steiner and Helios merger, with more than 62 hospitals and 18,000 beds.
  • Fresenius Omed : Medical project design, construction and operation management company, composed of Ogilvy Corporation and Hospitalia International Co., Ltd. ( Hospitalia International ). The service areas involve medical tourism, prevention, treatment, and health care. , Rehabilitation and elderly care.
  • Fresenius Biotechnology : Development and sales of biopharmaceutical products, mainly used in the fields of gene, tumor, transplantation and regenerative medicine.
  • Fresenius Network Service : Information technology company, mainly providing network technology solutions for the internal and external groups.

The Fresenius Group does not include the Fresenius Institute (Institut Fresenius) and the University of Fresenius (Hochschule Fresenius).

Fresenius SE & Co. (FSNUY) History:

  • The history of Fresenius SE & Co. KGaA can be traced back to 1462 when a pharmacy named “Hirsch” opened in Frankfurt am Main and was taken over by the Fresenius family in the 18th century.
  • In 1912, the owner and pharmacist of Hirsch Pharmacy, Edward Fresenius, formally established Fresenius, a pharmaceutical manufacturer, which was mainly responsible for the production of special medicines such as treatment plans, serum reagents and rhinitis ointments.
  • Between 1933 and 1934, the manufacturing company separated from the Hirsch Pharmacy and moved to Bad Homburg, and in the following years it had about 400 employees. However, the accidental death of Edward Fresenius in 1946 led to the dissolution of the pharmacy and production base. At this time, only 30 employees were still working.
  • In 1951, Else Kröner, a woman still known as Else Fernau and her husband Hans Kröner, started as a pharmacy And the medical research supervisor of the production company, and a new production line of intravenous injection equipment.
  • Since 1966, the company’s dialysis equipment and dialyzers have been sold to foreign manufacturers, and have occupied a considerable market share in this field.
  • In 1971, Fresenius successfully introduced an amino acid solution extracted from potato and egg samples, making a breakthrough in the field of gastrointestinal nutrition.
  • In 1974, the company set up a factory in St. Wendel, Saarland, mainly producing intravenous injections and disposable medical devices. Now it is also used to produce modern polysulfone membrane dialyzers.
  • Since 1979, the Schweinfurt plant in Bayern has also been in operation, where the world’s first volume balance chamber controlled ultrafiltration hemodialysis machine-A2008 was produced there.
  • In 1981, Fresenius was restructured into a joint-stock company and listed on the German Stock Exchange in 1986.
  • In 1983, the company began to apply synthetic polysulfone membranes to dialysis technology and established today’s quality standards.
  • In 1996, the Fresenius Dialysis Division merged with National Medical Care in the United States to form Fresenius Medical Co. , Ltd. , which is currently the world’s leading provider of dialysis products and services.
  • In 1997, Europe’s most modern intravenous supply factory was put into operation in Friedberg, Hessen.
  • In 1998, Fresenius acquired the international intravenous products business of Pharmacia & Upjohn and merged with the company’s pharmaceutical department to establish Fresenius Kabi, an infusion in Europe The treatment and clinical nutrition business occupies a dominant position. In the same year, the new headquarters building in Bad Homburg was completed.
  • In 2001, Fresenius acquired Wittgensteiner Kliniken AG (Wittgensteiner Kliniken AG) and took over 30 emergency and specialty hospitals and more than 4,600 employees.
  • In 2005, Fresenius purchased Helios Kliniken (Helios Kliniken) for a price of 1.5 billion euros. The business includes approximately 9,300 beds in 24 hospitals.
  • In 2006, Fresenius acquired RenalCare Group, a US nephropathy dialysis service company, and established its leading position in the dialysis market.
  • As of September 2007, a total of 172,000 patients in more than 2,200 hospitals providing dialysis services are using Fresenius products.
  • On December 4, 2006, Fresenius AG passed a resolution on its restructuring into a European stock company at its extraordinary general meeting of shareholders. The new name became effective on July 13, 2007.
  • On January 28, 2011, the legal status of Fresenius was changed again. The company announced that it would become a partnership with Europe Joint Stock Company as a partner with unlimited liability.
  • On September 6, 2016, Fresenius spent 5.76 billion euros ($6.42 billion) to acquire the Spanish medical group Quironsalud from shareholders such as private equity fund CVC Capital Partners.
Notify of
Inline Feedbacks
View all Intels

Software developer and seller: Smith Micro Software (SMSI)

Oil and gas company: Chesapeake Energy (CHK) (1989)